News

HIV’s Most Promising Breakthrough Has Taken a Hit
Several mRNA vaccine trials found a debilitating side effect, and now the Trump administration is cutting funding for more ...
New COVID vaccine approved by US FDA: Here's all about it
The US FDA has approved Moderna's new COVID-19 vaccine, mNEXSPIKE, amidst emerging coronavirus variants. It is approved for adults 65 and older, and i ...
KSL NewsRadio15d
Utah public health officials report new potential measles exposure
According to health officials, a traveler, who was visiting southwestern Utah was reportedly out in the community causing ...
cidrap.umn23d
Quick takes: Yellow fever risk, H5N1 avian flu case in China, updated Moderna COVID vaccine
The disease is also called "German measles." "Rubella virus infection usually produces a mild febrile rash illness in children and adults," the US Centers for Disease Control and Prevention-led ...
Moderna Receives U.S. FDA Approval for RSV Vaccine, mRESVIA, in Adults Aged 18–59 at Increased Risk for RSV Disease
Expanded indication builds on existing U.S. FDA approval of mRESVIA for adults aged 60 and older CAMBRIDGE, MA / ACCESS ...
FierceBiotech29d
Moderna withdraws FDA filing for flu/COVID combination vaccine, plans resubmission with efficacy data
Moderna has pulled the filing for FDA approval of its flu/COVID combination vaccine. The biotech plans to resubmit later this year with the phase 3 flu vaccine efficacy data the agency wants to see.
Detroit Free Press8d
Moderna Receives U.S. FDA Approval for RSV Vaccine, mRESVIA, in Adults Aged 18–59 at Increased Risk for RSV Disease
CAMBRIDGE, MA / ACCESS Newswire / June 12, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the U.S. Food and Drug Administration (FDA) has approved mRESVIA® (mRNA-1345), the Company’s ...